AI System for Detection and Characterization of Chronic Enteropathies
- Sponsor
- Istituti Clinici Scientifici Maugeri SpA
- Study ID
- NCT07387185
- Status
- Recruiting
Conditions
- Celiac Disease
- Non-celiac Enteropathies
- Small Bowel Mucosal Atrophy or Lesions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
Coeliac disease (CD) is an immune-mediated enteropathy leading to small intestinal mucosal atrophy. Diagnosis relies on serology and duodenal biopsies, but it can be complicated by patchy lesions and differential diagnosis with Non-Celiac Enteropathies (NCEs). This multicenter observational study aims to develop and validate an Artificial Intelligence (AI) system to detect and characterize small bowel mucosal atrophy and other pathological findings using endoscopic imaging. The study involves a retrospective phase for training the AI model and a prospective phase to validate its diagnostic accuracy compared to standard human assessment.
Key Dates
- First listed
- Feb 4, 2026
- Start date
- Feb 20, 2025
- Status verified
- Jan 2026
- Primary completion
- Mar 1, 2028
- Completion
- Mar 1, 2028
Study Design
- Enrollment
- 380 participants (estimated)
Arms
- Arm: Enteropathy Cohort (CD/NCE)Adult patients (\>=18 years) with suspected or confirmed Celiac Disease or Non-Celiac Enteropathies undergoing small bowel endoscopy.
- Arm: Control CohortAdult patients (\>=18 years) undergoing small bowel endoscopy who do not have enteropathy or other small bowel pathological lesions (negative controls).
- Arm: Other Small Bowel Lesion CohortAdult patients (\>=18 years) undergoing small bowel endoscopy who who do not have Celiac Disease or Non-Celiac Enteropathies but have other small bowel pathological lesions.
Primary Outcome Measure
Diagnostic Performance of the AI System [ Time Frame: Through study completion (36 months) ]
Central Contacts
- Federico Biagi, MD0382592695
Find similar trials
Related Studies
- Celiac Disease Genomic Environmental Microbiome and Metabolomic StudyRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- Imaging the Duodenum Using an Optical Frequency Domain Imaging OFDI CapsuleEnrolling By Invitation · Massachusetts General Hospital · Boston, Massachusetts
- General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care DeliveryRecruiting · Sanford Health · Bemidji, Minnesota
- Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation ResearchRecruiting · Brain Inflammation Collaborative · Delafield, Wisconsin